Codexis Appoints Vice President of Sales and Marketing
News Jun 06, 2013
Codexis, Inc. has announced the appointment of Scott Watson as Vice President of Sales and Marketing, effective May 2013.
Mr. Watson has more than 25 years of experience in sales, marketing and business development, including in the pharmaceutical and fine chemicals markets.
“Scott brings a strong track record of success to Codexis, along with a wealth of knowledge and connections from his various roles in the pharmaceutical and fine chemical industries,” said John Nicols, President and CEO of Codexis.
Nicols continued, “We continue to expand our pharmaceutical business through new collaborations with strategic partners, and this hire will allow us to capitalize on the many opportunities within both the pharmaceutical industry and other complex chemistry markets where our tailored enzymes can provide significant benefits for our customers.”
“Codexis is the world leader in developing biocatalysts for the pharmaceutical industry and I am very excited to be joining the team at this time,” said Scott Watson.
Watson continued, “The opportunities in the pharmaceutical market continue to grow, and I look forward to helping Codexis further expand its presence, in pharmaceutical and other complex chemistry markets, during the coming years.”
Before joining Codexis, Mr. Watson served most recently as the Executive Director of Sales and Marketing at AMPAC Fine Chemicals, a leading manufacturer of custom small molecule active pharmaceutical ingredients.
From 2008 to 2009, Mr. Watson served as Vice President of Sales and Marketing for Girindus, a diverse service company to the pharmaceutical industry, where he was responsible for realigning the company’s sales strategy.
Prior to Girindus, Mr. Watson held sales positions of growing responsibility with various companies, including Aptuit, DSM and Eastman Chemical Company.
Mr. Watson is a former officer in the U.S. Navy and holds a B.S. in Chemistry from the U.S. Naval Academy and an M.B.A. in Finance and Marketing from George Mason University.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018